Montelukast Sodium
Product Images NDC 67296-1482

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 67296-1482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharn Drug, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This is a line chart showing the change in height (cm) over weeks on treatment for three groups: montelukast sodium chewable tablets 5 mg, beclomethasone 336 mcg, and placebo. The x-axis represents weeks on treatment up to 48 weeks, and the y-axis shows height change from -2 to 8 cm.*
FDA Label Image
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph showing mean percent change from baseline over weeks in treatment for two groups: Placebo and Montelukast Sodium. The x-axis represents weeks in treatment (0, 3, 6, 9, 12, and 15), with a washout period starting after week 12. The y-axis indicates mean percent change from baseline, ranging from 0 to 15. Montelukast Sodium shows a higher increase compared to placebo throughout the treatment period.*
FDA Label Image

Montelukastsodium4mg30scount (Montelukastsodium4mg30scount)

Montelukastsodium4mg30scount (Montelukastsodium4mg30scount)
Montelukast Sodium chewable tablets label showing 4 mg strength, 30 count. Label includes NDC 31722-727-30 and states the product is for pediatric patients 2 to 5 years of age, prescription use only. Manufactured by Camber Pharmaceuticals, Inc., with packaging information and storage instructions visible.*
FDA Label Image

Montelukastsodium5mg30scount (Montelukastsodium5mg30scount)

Montelukastsodium5mg30scount (Montelukastsodium5mg30scount)
Montelukast Sodium Chewable Tablets 5 mg carton from Camber Pharmaceuticals, Inc. The package contains 30 tablets and is labeled for pediatric use in patients 6 to 14 years of age. The label includes a pharmacist instruction to dispense with a medication guide and storage instructions. Manufactured by Camber Pharmaceuticals, Inc., New Jersey, and by Hetero Labs Limited, India.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of montelukast sodium showing its molecular framework with labeled atoms and bonds, including chlorine, sulfur, and carboxylate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.